Jan 11, 2010 (PRN): NASDAQ OMX Group's Educational Foundation Inc., the global securities trading network's special concessionary funding organisation, has awarded a block grant worth US$25,000, which will support Remedi's UK-based research into rehabilitative aspects of sometimes severe medical conditions. These conditions can often result in physical impairment, activity limitation and/or a reduction in quality of life.

The funding of research projects into rehabilitation can offer both patients and their families a way back to normal living, or in more severe cases, to adjust appropriately to new circumstances.

Remedi typically provides research grants ranging from GBP 1,000 to GBP 60,000, as well as one major award each year worth up to GBP 200,000. Remedi's specialist Scientific Advisory Committee reviews applications for specific research grants twice yearly (in May and October), which are then submitted to the charity's trustees for final approval.

The NASDAQ OMX funds will contribute to the Remedi Clinical Research Fellowship in Cancer Rehabilitation. This Fellowship has latterly been awarded to Dr. Isabel White, a post-doctoral clinical research fellow at the Florence Nightingale School of Nursing and Midwifery at King's College London. Dr. White works clinically at leading London hospitals, with a specific interest in the development of a clinical assessment system for relationship difficulties in women treated by radical pelvic radiotherapy for cervical or endometrial cancer. The Fellowship award is for three years in the first instance. However, Remedi's trustees are now seeking additional funding to help finance an additional two years (Years 4 & 5) for the Fellowship.

The NASDAQ OMX Group is one of the world's largest securities exchange companies, working across six continents. The NASDAQ OMX Education Foundation focuses its initiatives to promote learning about capital formation, financial markets and entrepreneurship.

The grant of US$25,000 to Remedi extends the commitment of the NASDAQ OMX Group to support an initiative important to the finance community in the city of London.

"Remedi has a long history of working with leading institutions in the financial markets to extend the capacity of the charity to provide support for vital research into rehabilitation projects and clinical innovation," said Rosie Wait, director, Remedi. "We would like to take this opportunity to thank NASDAQ OMX for its valuable contribution to our work and we hope it is the start of a long association with the group. Moreover, Remedi is keen to work with other leading financial institutions in a similar capacity."

"It is encouraging that key financial market innovators, such as the NASDAQ OMX Group, are intent on supporting research into medical innovation and rehabilitation and making a valuable contribution to improved living conditions for sufferers of sometimes chronic and debilitating illness," said Dr. Tony Clarke, chairman of Remedi.

"NASDAQ OMX is an institution that supports companies and organisations like Remedi that have a vision to improve quality of life and historically, NASDAQ OMX has supported capital formation for revolutionary medical and biotechnology companies. We are very pleased to support the Remedi Clinical Research Fellowship in Cancer Rehabilitation," said Charlotte Crosswell, President of NASDAQ OMX Europe, who will be running for Remedi in the Virgin London Marathon on April 25th, 2010.

For more information on the work of Remedi, please visit http://www.remedi.org.uk or contact:

Rosie Wait

Director, Remedi

Tel: + 00 44 (207) 384 2929

Email: info@remedi.org.uk

For more information about NASDAQ OMX and its support of educational and research projects, please visit http://www.nasdaqomx.com/whoweare/educationalinitiative/ or contact:

Bethany Sherman

Tel: (212) 401-8714

Email: Bethany.Sherman@NASDAQOMX.com

Robert Madden

Tel: (646) 441-5045

Email: Robert.Madden@NASDAQOMX.com

For more information about the Florence Nightingale School of Nursing and Midwifery please contact:

Frances Dodd

Communications Officer

Tel: + 020 7848 3062

Email: frances.dodd@kcl.ac.uk

About Florence Nightingale School of Nursing and Midwifery, King's College London

The Florence Nightingale School of Nursing and Midwifery at King's College London is the world's first professional School of nursing established by Florence Nightingale in 1860.

The number one Nursing and Midwifery School in London and highly regarded by leading London NHS Trusts with links to industry, health services and policy makers, the School develops leading-edge nurses and midwives of tomorrow - practitioners, partners, and leaders in their field. The School is at the forefront of health services, policy and evaluation research and home to the influential National Nursing Research Unit (NNRU) - the only Department of Health-funded unit of its kind in England. For further information visit www.kcl.ac.uk/schools/nursing

About Remedi

Remedi provides funds for medical research projects in the UK which will result in new rehabilitation procedures, improved medical equipment, services and facilities which dramatically improve the quality of life for babies, children and adults and make the journey from illness or disability back to a normal life a reality.

Established as a registered Charity for nearly 35 years, the work at Remedi is ever more important as medical science enables people to live with illness and disease and therefore their ability to live a normal life, return to work and be able to function as an individual, becomes ever more crucial.

The medical research we support in rehabilitation and disability projects, often complete the "incubator" or pilot study stage and this enables researchers to then seek funding from large organisations such as the Medical Research Council, who will then fund a much larger project to complete the studies which enables new advances in care for these diseases. In the last 15 years Remedi has awarded GBP 4 million pounds to projects.

About NASDAQ OMX Education Foundation

The mission of the NASDAQ OMX Education Foundation is to promote learning about capital formation, financial market and entrepreneurship through innovative educational programs. It was established in New York City in 1994 and is supported entirely by contributions from The NASDAQ OMX Group, Inc.

About NASDAQ OMX

The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with approximately 3,700 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. [Wired by: PressReleaseNetwork.com]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.